Logo image of EMX

EMX ROYALTY CORP (EMX) Stock Fundamental Analysis

NYSEARCA:EMX - NYSE Arca - CA26873J1075 - Common Stock - Currency: USD

3.13  +0.03 (+0.97%)

After market: 3.2 +0.07 (+2.24%)

Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to EMX. EMX was compared to 154 industry peers in the Metals & Mining industry. EMX scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. EMX is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

EMX had negative earnings in the past year.
In the past year EMX had a positive cash flow from operations.
In the past 5 years EMX reported 4 times negative net income.
In multiple years EMX reported negative operating cash flow during the last 5 years.
EMX Yearly Net Income VS EBIT VS OCF VS FCFEMX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M 60M

1.2 Ratios

Looking at the Return On Assets, with a value of 0.13%, EMX is in line with its industry, outperforming 55.84% of the companies in the same industry.
EMX's Return On Equity of 0.17% is in line compared to the rest of the industry. EMX outperforms 55.84% of its industry peers.
With a Return On Invested Capital value of 1.53%, EMX perfoms like the industry average, outperforming 50.65% of the companies in the same industry.
Industry RankSector Rank
ROA 0.13%
ROE 0.17%
ROIC 1.53%
ROA(3y)-1.01%
ROA(5y)-4.61%
ROE(3y)-1.33%
ROE(5y)-6.3%
ROIC(3y)N/A
ROIC(5y)N/A
EMX Yearly ROA, ROE, ROICEMX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40

1.3 Margins

The Profit Margin of EMX (0.67%) is better than 60.39% of its industry peers.
EMX has a better Operating Margin (9.93%) than 64.94% of its industry peers.
Industry RankSector Rank
OM 9.93%
PM (TTM) 0.67%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
EMX Yearly Profit, Operating, Gross MarginsEMX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1K 2K

More info and screens

5

2. Health

2.1 Basic Checks

EMX has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
The number of shares outstanding for EMX has been reduced compared to 1 year ago.
The number of shares outstanding for EMX has been increased compared to 5 years ago.
Compared to 1 year ago, EMX has a worse debt to assets ratio.
EMX Yearly Shares OutstandingEMX Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M
EMX Yearly Total Debt VS Total AssetsEMX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M

2.2 Solvency

EMX has an Altman-Z score of 6.90. This indicates that EMX is financially healthy and has little risk of bankruptcy at the moment.
EMX has a Altman-Z score of 6.90. This is in the better half of the industry: EMX outperforms 77.92% of its industry peers.
A Debt/Equity ratio of 0.30 indicates that EMX is not too dependend on debt financing.
EMX's Debt to Equity ratio of 0.30 is on the low side compared to the rest of the industry. EMX is outperformed by 61.69% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.3
Debt/FCF N/A
Altman-Z 6.9
ROIC/WACC0.17
WACC9.02%
EMX Yearly LT Debt VS Equity VS FCFEMX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M 100M

2.3 Liquidity

A Current Ratio of 8.56 indicates that EMX has no problem at all paying its short term obligations.
Looking at the Current ratio, with a value of 8.56, EMX belongs to the top of the industry, outperforming 88.96% of the companies in the same industry.
EMX has a Quick Ratio of 8.56. This indicates that EMX is financially healthy and has no problem in meeting its short term obligations.
EMX's Quick ratio of 8.56 is amongst the best of the industry. EMX outperforms 88.96% of its industry peers.
Industry RankSector Rank
Current Ratio 8.56
Quick Ratio 8.56
EMX Yearly Current Assets VS Current LiabilitesEMX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M

More info and screens

5

3. Growth

3.1 Past

EMX shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 107.75%, which is quite impressive.
EMX shows a decrease in Revenue. In the last year, the revenue decreased by -1.62%.
EMX shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 40.11% yearly.
EPS 1Y (TTM)107.75%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%158.08%
Revenue 1Y (TTM)-1.62%
Revenue growth 3Y42.76%
Revenue growth 5Y40.11%
Sales Q2Q%34.97%

3.2 Future

Based on estimates for the next years, EMX will show a very strong growth in Earnings Per Share. The EPS will grow by 63.03% on average per year.
The Revenue is expected to grow by 6.70% on average over the next years.
EPS Next Y200%
EPS Next 2Y82.57%
EPS Next 3Y63.03%
EPS Next 5YN/A
Revenue Next Year-7.81%
Revenue Next 2Y1.93%
Revenue Next 3Y6.7%
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
EMX Yearly Revenue VS EstimatesEMX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 10M 20M 30M
EMX Yearly EPS VS EstimatesEMX Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 0 0.05 -0.05 0.1 -0.1 -0.15

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Forward Earnings ratio of 103.46, EMX can be considered very expensive at the moment.
EMX's Price/Forward Earnings is on the same level as the industry average.
When comparing the Price/Forward Earnings ratio of EMX to the average of the S&P500 Index (37.64), we can say EMX is valued expensively.
Industry RankSector Rank
PE N/A
Fwd PE 103.46
EMX Price Earnings VS Forward Price EarningsEMX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

The rest of the industry has a similar Enterprise Value to EBITDA ratio as EMX.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 49.39
EMX Per share dataEMX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.2 0.4 0.6

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
EMX's earnings are expected to grow with 63.03% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y82.57%
EPS Next 3Y63.03%

More info and screens

0

5. Dividend

5.1 Amount

EMX does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

EMX ROYALTY CORP

NYSEARCA:EMX (7/25/2025, 8:04:00 PM)

After market: 3.2 +0.07 (+2.24%)

3.13

+0.03 (+0.97%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryMetals & Mining
Earnings (Last)05-11 2025-05-11/amc
Earnings (Next)08-11 2025-08-11
Inst Owners17.57%
Inst Owner Change1.07%
Ins Owners14.98%
Ins Owner ChangeN/A
Market Cap341.73M
Analysts84.44
Price Target3.52 (12.46%)
Short Float %0.14%
Short Ratio0.29
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0.23%
PT rev (3m)16.95%
EPS NQ rev (1m)0%
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-9.92%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 103.46
P/S 15.71
P/FCF N/A
P/OCF 65.73
P/B 4.04
P/tB 4.04
EV/EBITDA 49.39
EPS(TTM)0
EYN/A
EPS(NY)0.03
Fwd EY0.97%
FCF(TTM)-0.03
FCFYN/A
OCF(TTM)0.05
OCFY1.52%
SpS0.2
BVpS0.78
TBVpS0.78
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 0.13%
ROE 0.17%
ROCE 1.94%
ROIC 1.53%
ROICexc 1.85%
ROICexgc 1.85%
OM 9.93%
PM (TTM) 0.67%
GM N/A
FCFM N/A
ROA(3y)-1.01%
ROA(5y)-4.61%
ROE(3y)-1.33%
ROE(5y)-6.3%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score6
Asset Turnover0.19
Health
Industry RankSector Rank
Debt/Equity 0.3
Debt/FCF N/A
Debt/EBITDA 3.69
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage 1.09
Cash Conversion 75.55%
Profit Quality N/A
Current Ratio 8.56
Quick Ratio 8.56
Altman-Z 6.9
F-Score6
WACC9.02%
ROIC/WACC0.17
Cap/Depr(3y)25.77%
Cap/Depr(5y)19.56%
Cap/Sales(3y)6.62%
Cap/Sales(5y)4.87%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)107.75%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%158.08%
EPS Next Y200%
EPS Next 2Y82.57%
EPS Next 3Y63.03%
EPS Next 5YN/A
Revenue 1Y (TTM)-1.62%
Revenue growth 3Y42.76%
Revenue growth 5Y40.11%
Sales Q2Q%34.97%
Revenue Next Year-7.81%
Revenue Next 2Y1.93%
Revenue Next 3Y6.7%
Revenue Next 5YN/A
EBIT growth 1Y-31.7%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year3013.71%
EBIT Next 3Y238.26%
EBIT Next 5YN/A
FCF growth 1Y44.82%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y220.22%
OCF growth 3YN/A
OCF growth 5YN/A